Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo

Aguado-Martínez, 2017, Neospora caninum in non-pregnant and pregnant mouse models: cross-talk between infection and immunity, Int. J. Parasitol., 47, 723, 10.1016/j.ijpara.2017.09.001 Aguado-Martinez, 2016, N-terminal fusion of a toll-like receptor 2-ligand to a Neospora caninum chimeric antigen efficiently modifies the properties of the specific immune response, Parasitology, 143, 606, 10.1017/S0031182016000056 Aguado-Martínez, 2019, Immunization with a cocktail of antigens fused with OprI reduces Neospora caninum vertical transmission and postnatal mortality in mice, Vaccine, 37, 473, 10.1016/j.vaccine.2018.11.060 Alaeddine, 2013, Molecular cloning and characterization of NcROP2Fam-1, a member of the ROP2 family of rhoptry proteins in Neospora caninum that is targeted by antibodies neutralizing host cell invasion in vitro, Parasitology, 140, 1033, 10.1017/S0031182013000383 Anghel, 2018, Endochin-like quinolones exhibit promising efficacy against neospora caninum in vitro and in experimentally infected pregnant mice, Front. Vet. Sci., 5, 10.3389/fvets.2018.00285 Anghel, 2020, Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice, Int. J. Antimicrob. Agents, 56, 10.1016/j.ijantimicag.2020.106099 Arranz-Solís, 2015, Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model, Vet. Parasitol., 211, 133, 10.1016/j.vetpar.2015.05.021 Barna, 2013, In Vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites, Antimicrob. Agents Chemother., 57, 5747, 10.1128/AAC.02446-12 Björkman, 1998, Characterization of Neospora caninum iscom antigens using monoclonal antibodies, Parasite Immunol., 20, 73, 10.1046/j.1365-3024.1998.00127.x Castellanos-Gonzalez, 2013, A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis, J. Infect. Dis., 208, 1342, 10.1093/infdis/jit327 Debache, 2009, Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites, Int. J. Parasitol., 39, 1373, 10.1016/j.ijpara.2009.04.006 Debache, 2008, Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites, Int. J. Parasitol., 38, 1455, 10.1016/j.ijpara.2008.04.001 Dellarupe, 2014, Clinical outcome and vertical transmission variability among canine Neospora caninum isolates in a pregnant mouse model of infection, Parasitology, 141, 356, 10.1017/S0031182013001479 Doggett, 2012, Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis, Proc. Natl. Acad. Sci. U.S.A., 109, 15936, 10.1073/pnas.1208069109 Doggett, 2014, Bumped kinase inhibitor 1294 treats established toxoplasma gondii infection, Antimicrob. Agents Chemother., 58, 3547, 10.1128/AAC.01823-13 Doggett, 2020, Orally bioavailable endochin-like quinolone carbonate ester prodrug reduces toxoplasma gondii brain cysts, Antimicrob. Agents Chemother., 64, 10.1128/AAC.00535-20 Dubey, 1988, Newly recognized fatal protozoan disease of dogs, J. Am. Vet. Med. Assoc., 192, 1269 Dubey, 2017 Dubey, 2011, Gray wolf (Canis lupus) is a natural definitive host for Neospora caninum, Vet. Parasitol., 181, 382, 10.1016/j.vetpar.2011.05.018 Gondim, 2004, Coyotes (Canis latrans) are definitive hosts of Neospora caninum, Int. J. Parasitol., 34, 159, 10.1016/j.ijpara.2004.01.001 Guionaud, 2010, Molecular characterization of Neospora caninum MAG1, a dense granule protein secreted into the parasitophorous vacuole, and associated with the cyst wall and the cyst matrix, Parasitology, 137, 1605, 10.1017/S0031182010000442 Horcajo, 2016, Vaccines for bovine neosporosis: current status and key aspects for development, Parasite Immunol., 38, 709, 10.1111/pim.12342 Hulverson, 2019, Pharmacokinetics and in vivo efficacy of pyrazolopyrimidine, pyrrolopyrimidine, and 5-aminopyrazole-4-carboxamide bumped kinase inhibitors against toxoplasmosis, J. Infect. Dis., 219, 1464, 10.1093/infdis/jiy664 Imhof, 2021, In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts, Int. J. Parasitol. Drugs Drug Resist., 16, 90, 10.1016/j.ijpddr.2021.05.001 Jiménez-Meléndez, 2017, In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites, Int. J. Parasitol., 47, 811, 10.1016/j.ijpara.2017.08.005 Kappagoda, 2011, Antiparasitic therapy, Mayo Clin. Proc., 10.4065/mcp.2011.0203 Keyloun, 2014, The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites, 1499 Kieschnick, 2001, Toxoplasma gondii attachment to host cells is regulated by a calmodulin-like domain protein kinase, J. Biol. Chem., 276, 12369, 10.1074/jbc.M011045200 King, 2010, Australian dingoes are definitive hosts of Neospora caninum, Int. J. Parasitol., 40, 945, 10.1016/j.ijpara.2010.01.008 Lawres, 2016 Martynowicz, 2020, Efficacy of guanabenz combination therapy against chronic toxoplasmosis across multiple mouse strains, Antimicrob. Agents Chemother., 64, 10.1128/AAC.00539-20 McAllister, 1998, Dogs are definitive hosts of Neospora caninum, Int. J. Parasitol., 28, 1473, 10.1016/S0020-7519(98)00138-6 McCann, 2008, Lack of serologic evidence of neospora caninum in humans, england, Emerg. Infect. Dis., 14, 978, 10.3201/eid1406.071128 McConnell, 2018, Targeted structure-activity analysis of endochin-like quinolones reveals potent Qi and qo site inhibitors of toxoplasma gondii and Plasmodium falciparum cytochrome bc1 and identifies ELQ-400 as a remarkably effective compound against acute experimental to, ACS Infect. Dis., 4, 1574, 10.1021/acsinfecdis.8b00133 Miley, 2015, ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria, Antimicrob. Agents Chemother., 59, 5555, 10.1128/AAC.01183-15 Monney, 2014, Vaccines against neosporosis: what can we learn from the past studies?, Exp. Parasitol., 140, 52, 10.1016/j.exppara.2014.02.015 Müller, 2017, Two novel calcium-dependent protein kinase 1 inhibitors interfere with vertical transmission in mice infected with Neospora caninum tachyzoites, Antimicrob. Agents Chemother., 61, 10.1128/AAC.02324-16 Müller, 2016, Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model, Vet. Res., 47, 32, 10.1186/s13567-016-0317-1 Müller, 2017, Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis, J. Antimicrob. Chemother., 72, 2334, 10.1093/jac/dkx134 Müller, 2002, Application of real-time fluorescent PCR for quantitative assessment of Neospora caninum infections in organotypic slice cultures of rat central nervous system tissue, J. Clin. Microbiol., 40, 252, 10.1128/JCM.40.1.252-255.2002 Nilsen, 2013, Quinolone-3-diarylethers: a new class of antimalarial drug, Sci. Transl. Med., 5, 10.1126/scitranslmed.3005029 Ojo, 2016, Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy, Int. J. Parasitol., 46, 871, 10.1016/j.ijpara.2016.08.003 Ojo, 2014, Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy, PloS One, 9, 10.1371/journal.pone.0092929 Pedroni, 2016, Bumped kinase inhibitor prohibits egression in Babesia bovis, Vet. Parasitol., 215, 22, 10.1016/j.vetpar.2015.10.023 Pink, 2005, Opportunities and challenges in antiparasitic drug discovery, Nat. Rev. Drug Discov., 10.1038/nrd1824 Reichel, 2013, What is the global economic impact of Neospora caninum in cattle - the billion dollar question, Int. J. Parasitol., 43, 133, 10.1016/j.ijpara.2012.10.022 Rosenthal, 2003, Antimalarial drug discovery: old and new approaches, J. Exp. Biol., 206, 3735, 10.1242/jeb.00589 Rutaganira, 2017, Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by toxoplasma gondii, J. Med. Chem., 60, 9976, 10.1021/acs.jmedchem.7b01192 Sánchez-Sánchez, 2019, Treatment with bumped kinase inhibitor 1294 is safe and leads to significant protection against abortion and vertical transmission in sheep experimentally infected with toxoplasma gondii during pregnancy, Antimicrob. Agents Chemother., 63, 1, 10.1128/AAC.02527-18 Sánchez-Sánchez, 2018, Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites, Int. J. Parasitol. Drugs Drug Resist., 8, 112, 10.1016/j.ijpddr.2018.02.003 Schorer, 2012, Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice, Int. J. Parasitol. Drugs Drug Resist., 2, 109, 10.1016/j.ijpddr.2012.03.001 Shrestha, 2019, Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro, Int. J. Parasitol. Drugs Drug Resist., 10, 9, 10.1016/j.ijpddr.2019.03.004 Stickles, 2016, Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc1 inhibition strategy for malaria, Antimicrob. Agents Chemother., 60, 4853, 10.1128/AAC.00791-16 Stickles, 2015, Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy, Am. J. Trop. Med. Hyg., 92, 1195, 10.4269/ajtmh.14-0553 Sun, 2016, Drug combination therapy increases successful drug repositioning, Drug Discov. Today, 21, 1189, 10.1016/j.drudis.2016.05.015 Van Voorhis, 2017, Extended-spectrum antiprotozoal bumped kinase inhibitors: a review, Exp. Parasitol., 180, 71, 10.1016/j.exppara.2017.01.001 Whitten, 1957, Effect of exteroceptive factors on the œstrous cycle of mice [40], Nature, 10.1038/1801436a0 Winter, 2011, Optimization of endochin-like quinolones for antimalarial activity, Exp. Parasitol., 127, 545, 10.1016/j.exppara.2010.10.016 Winzer, 2020, Neospora Caninum: Structure and Fate of Multinucleated Complexes Induced by the Bumped Kinase Inhibitor Bki-1294, Pathogens, 9, 10.3390/pathogens9050382 Winzer, 2020, The impact of BKI-1294 therapy in mice infected with the apicomplexan parasite neospora caninum and Re-infected during pregnancy, Front. Vet. Sci., 7, 1, 10.3389/fvets.2020.587570 Winzer, 2015, In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum, Antimicrob. Agents Chemother., 59, 6361, 10.1128/AAC.01236-15 Winzer, 2020, Neospora caninum: differential proteome of multinucleated complexes induced by the bumped kinase inhibitor BKI-1294, Microorganisms, 8, 801, 10.3390/microorganisms8060801